Therefore, CYP2C19 polymorphism is considered as one of the factors that determine an individual’s cancer susceptibility by the interindividually different ability of detoxification of carcinogen(s) and/or activation of procarcinogen(s) [41,42]. The gene discussed is CYP2C19; the disease is cancer.